Epirubicin hydrochloride 盐酸表柔比星(抗肿瘤药) L-阿拉伯糖衍生物|CAS 56390-09-1（54617ES）

Epirubicin hydrochloride，又称盐酸表柔比星，是阿霉素的半合成L-阿拉伯糖衍生物，通过抑制DNA拓扑异构酶和与DNA形成复合物而发挥抗肿瘤作用，临床上用于治疗多种肿瘤。

参考文献

[1] Cersosimo RJ, Hong WK. Epirubicin: a review of the pharmacology, clinical activity, and adverse effects of an adriamycin analogue. J Clin Oncol. 1986 Mar;4(3):425-39. doi: 10.1200/JCO.1986.4.3.425(IF:28.245).

[2] Ozkan A, Fişkin K. Epirubicin HCl toxicity in human-liver derived hepatoma G2 cells. Pol J Pharmacol. 2004 Jul-Aug;56(4):435-44.

[3] Asanuma F, Yamada Y, Kawamura E, et al. Antitumor activity of paclitaxel and epirubicin in human breast carcinoma, R-27. Folia Microbiol (Praha). 1998;43(5):473-4. doi: 10.1007/BF02820793(IF:1.448).

[4] Bonadonna G, Gianni L, Santoro A, et al. Drugs ten years later: epirubicin. Ann Oncol. 1993 May;4(5):359-69. doi: 10.1093/oxfordjournals.annonc.a058514(IF:14.196).

-25~-15℃保存，有效期3年。